Lower expression of key ATGs (BECN1, ATG3, ATG5, ATG4, ATG14) was shown in a large panel of primary acute myeloblastic leukemia (AML) patients as compared to normal granulocytes [65]. Here, BECN1 is linked to acute myeloid leukemia.